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Introduction: After a systemic trealment with oraI isotretinoin. acne therapy must be continued with topical products in order to avoid possible
 
relapses. The aim of this study was to assess whether a topical retinoid is an effective choice in the prevention of relapses.
 
Methods: Patients who were successfully treated with oral isotrelinoin for severe acne, allhe end of lhe therapy were randomized Inlo !WO groups: lha
 
firsl one was lrealed wilh a topical relinoid (0.05% trelinoin or 0.05% isotrelinoin or 0.1 % adapalene, 1 applicalion/day for 6·8 monlhs); lhe second group
 
was nollrealed (only delergents and moislurizers were allowed). Follow up was >6 monlhs.
 
Results: Allhe end of lhe sludy, 2/37 palients (5.4%) lrealed with lopical' retinoids developed a relapse; in lhe group of palients who were noi treated,
 
7/31 palients (22.6%) developed a relapse (p< 0.05).
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